NCT05300542View on ClinicalTrials.gov

Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

March 17, 2022

Primary Completion Date

March 31, 2022

Study Completion Date

April 13, 2022

Conditions
ErythemaSun Damaged SkinSkin Inflammation
Interventions
OTHER

Topical Placebo Cream

Application of test products before and after irradiation

OTHER

Topical Cream with 0.5% Active

Application of test products before and after irradiation

OTHER

Topical Cream with 1% Active

Application of test products before and after irradiation

Trial Locations (1)

Unknown

proderm GmbH, Schenefeld

All Listed Sponsors
collaborator

proDERM GmbH

INDUSTRY

lead

Amazentis SA

INDUSTRY